BridgeBio Pharma BBIO
NASDAQ BBIO
$65.97 -0.64 (-0.96%)
At close: Sep 29, 2026 · 4:00 PM EDT

BridgeBio Pharma (BBIO) Divestments (2021 - 2025)

Updated

BridgeBio Pharma (BBIO) recorded Divestments of $2.3 million in FY2025, down 91.0% from $25.68 million in FY2024.

Analysis

BridgeBio Pharma (BBIO) Divestments (2021 - 2025) Analysis & Trends

  • Annual Divestments has a four-year compound annual growth rate of -49.0% (FY2021 to FY2025).
  • Per Business Quant data, BBIO's Divestments was $25.68 million in FY2024 and $34.15 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 87.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 1.88 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 BridgeBio Pharma 13.01 Bn 10.12 Bn 228.63 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 2.30 Mn
Mar 31, 2024 25.68 Mn
Dec 31, 2021 29.41 Mn
API Access

BridgeBio Pharma Divestments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=divestments&ticker=BBIO&period=max&api_key=YOUR_API_KEY